| Gene symbol | FOSL1 | Synonyms | FRA, FRA1, fra-1 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q13.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | FOS like 1, AP-1 transcription factor subunit | ||||
| Gene symbol | FOLH1 | Synonyms | FGCP, FOLH, GCP2, GCPII, NAALAD1, PSM, PSMA, mGCP | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11p11.12 | dbXrefs | |
| Description | folate hydrolase 1 | ||||
| GTO ID | GTC1742 |
| Trial ID | NCT03185468 |
| Disease | Bladder Cancer |
| Altered gene | PSMA|FRa |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | PSMA/FRa CAR-T cells |
| Generation | 4th |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | Intervention of Advanced or Metastatic Urothelial Bladder Cancer by 4SCAR-T Cell Therapies |
| Year | 2017 |
| Country | China |
| Company sponsor | Shenzhen Geno-Immune Medical Institute |
| Other ID(s) | GIMI-IRB-17004 |
| Cohort1: PSMA | |||||
|
|||||
| Cohort2: FRa | |||||
|
|||||